Saisie de commande
Switzerland
Lien pour commandesContactUsLinkComponent
Ninhydrin Amine detection reagent

Ninhydrin Amine detection reagent

N° de catalogue ABCAAB146213-25
Marketsource
Fournisseur:   Abcam
Ninhydrin Amine detection reagent
N° de catalogue ABCAAB146213-25
Fournisseur:  Abcam
Marketsource
Numéro CAS:  485-47-2
Ninhydrin Amine detection reagent
Numéro CAS:  485-47-2
Prix
74.90 SFr.
Connexion Pour la disponibilité
1 * 25 g
Product Details & Documents

Ninhydrin reacts with a mMonia and primary and secondary amines producing a blue or purple reaction product (diketohydrindylidene-diketohydrindamine). Co mMonly used for the development of fingermarks on porous surfaces. Also useful in the analysis of free amino groups in proteins, peptides and amino acids. May be useful for detecting ninhydrin-reactive nitrogens in soil for forensic applications.

Attention: All products are FOR RESEARCH USE ONLY. PRODUCTS ARE NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. Customer is granted a limited use non-exclusive licence for its own internal research. Any control manufacturer supplies with a Product is limited to use only to validate the relevant Product. By using the Product, Customers agree not to attempt to reverse engineer or otherwise perform any compositional, structural, functional or other analyses directed to learning the methodology, formulae, sequences, processes, make-up or production of any of the Products or portions thereof.

Synonymes:  Ninhydrin monohydrate, Trioxohydrindene monohydrate, 2,2-Dihydroxyindane-1,3-dione, 2,2-Dihydroxy-1,3-indanedione, Indanetrione hydrate, 2,2-Dihydroxyindan-1,3-dion, 1,2,3-Indantrione monohydrate
  • Numéro CAS:485-47-2
  • Poids moléculaire:178,14 g/mol
Spécifications

Résultats des tests de spécification

  • Constituents::
    100% Ninhydrin
Recommendations

Recommendations will be personalized based on your shopping preferences only if you have given your consent by enabling "Enhance my Shopping Experience" on the "Personal Info page".

Otherwise, you will receive generic recommendations.